| Sl No | Title | Year | Duration | Name of the Funding Agency | Total grant Lakhs(Rs) |
|---|---|---|---|---|---|
| 1 | Gap assessment of Health and wellness centres in Yadgir district-A health system strengthening project by UNICEF | 2019-2020 | 6 Months | Unicef | 7.74 |
| 2 | Iodine deficiency disorder survey of Mysuru- A Government of Karnataka project | 2019-2020 | 1 Year | Dept of Health and Family Welfare, Govt of Karnataka | 1.0 |
| 3 | WHO Unity study -Risk factors for SARS-CoV2 infection among health care workers in India: (A controlled study from WHO) | 2020-2021 | 1 Year | WHO | 8.3 |
| 4 | Effectiveness of covaxin and covishield vaccines against severe COVID-19 in India,2021: A multi-centric hospital-based case-control study | 2021-2022 | 3 Months | ICMR-NIE | 10.95 |
| 5 | WHO O2 COV2: Oxygen requirements and approaches to respiratory support in patients with COVID-19 in low- and middle-income countries: a WHO study | 2021-2022 | 6 Month | WHO | 23.5 |
| 6 | Exploring the factors that act as barriers and facilitators for the utilization of eSanjeevani ABHWC and eSanjeevani OPD in Karnataka, India | 2021 | 3 Months | BMGF | 4.0 |
| 7 | Cost of Illness and Diabetes-Specific Quality of Life among Type-1 Diabetic Adolescents in Mysore | 2022 | 12 Months | MAMTA Health Institute for Mother and Child | 1.0 |
| 8 | A Prospective, Multicentre, Randomised, Active- controlled, Observer-blind, Phase II study seamlessly followed by a Phase III study to evaluate the Safety, Tolerability, and Immunogenicity of the Candidate HGCO19 (COVID-19 vaccine) in healthy subjects. | 2021-2022 | 15 Months | Gennova | 34 |
| 9 | Ambari – Sickle cell disease Health System Strengthening Project | 2022-2023 | 12 Months | Novartis | 28 |
| 10 | Dengue Vaccine Trial | 2022-2025 | 36 Months | ICMR | 86.78 |